Global HealthCare Insights Magazine - International coverage of hospitals and health systems

Q&A: CallisonRTKL’s Brad Barker

Building hospitals in The Middle East and China is big business — if you can get paid and protect intellectual property.

JCI Accreditation: How Hospitals in the UAE and China Did It

The challenges to a top accreditation are significant, but so are the benefits.

Q&A: Figure 1’s Josh Wildstein

A digital healthcare startup improves information sharing among physicians and goes global fast.

How One India State is Becoming a Global Pharmaceutical Giant

Gujarat’s government has pumped up industrial infrastructure and regulatory compliance, to India’s pharmaceutical industry’s benefit.

Become an Influencer Subscriber

Influencers get direct access to our team of analysts and researchers, along with the special Influencer-only content.

Q&A: CallisonRTKL’s Brad Barker
JCI Accreditation: How Hospitals in the UAE and China Did It
Q&A: Figure 1’s Josh Wildstein
How One India State is Becoming a Global Pharmaceutical Giant
Become an Influencer Subscriber

Executive Interviews

Q&A: Thomas Coffman on Duke’s Singapore Medical-School Venture

Singapore wanted a state-of-the-art, graduate-entry medical school. With the help of Duke University, the new school has thrived.

Q&A: CallisonRTKL’s Brad Barker
Q&A: Global Healthcare Accreditation, Karen Timmons
Q&A: Gustavo Fernandez de Loyola, Grupo Torre Médica

Hospital Profiles

São Paulo Hospital a Leader in Kidney Transplants

A kidney hospital is shaping the transplantation scene in Latin America and beyond.

Women’s Health Takes Center Stage at Al Khalidi Center in Amman
A Public Hospital Struggles to Lead Ghana Healthcare
A Kenya Hospital Merges Quality and Efficiency with Mission

Institutional Collaborations

How to Structure a Profitable International Healthcare Deal

U.S. healthcare providers are striking global partnerships. Here are ways to make the deals pay off.

Turning Risk Into Opportunity in International Healthcare Partnerships
Holistic Fertility Care in the UAE: Where East Meets West
JCI Accreditation: How Hospitals in the UAE and China Did It

Tata Enters Advanced Cancer-Care Pact with India State

Five new treatment centers and specialty training will attack Assam’s high untreated-cancer rate.

A Philippines Primary-Care Network Aims to Offer What the Government Can’t

With government facilities in short supply, Ayala Health hopes that convenient access and service integration will bring patients into its new clinics.

UnitedHealth Pauses Brazil Acquisition Spree to Strengthen IT

After a stunning run of hospital and clinic buys in Brazil, the U.S. insurance giant is putting its now-sprawling house in order.

Brazil’s Drug Shortages Lead to Calls for Public-Private Partnerships

How One India State is Becoming a Global Pharmaceutical Giant

Egypt Drug Prices Climb In Face of Shortages

Artificial Intelligence, China’s Newest Technology Temptress

Q&A: Figure 1’s Josh Wildstein

Spain’s Healthcare-Innovation Engine

Elevating Nursing at Two Latin America Hospitals

China’s Growing Prostate-Cancer Problem

São Paulo Hospital a Leader in Kidney Transplants

China’s Growing Prostate-Cancer Problem

A surgeon in Shanghai leads the battle on rising rates, poor outcomes and anatomical obstacles.

Holistic Fertility Care in the UAE: Where East Meets West

A Nigeria Hospital Tackles Mental Illness

In Peru, Letting Insurers Buy Hospitals Pays Off in Higher Quality

Big players in Peruvian healthcare are moving towards vertical integration of delivery and insurance. But what does that mean for patients?

LeapFrog Investments Hops into Africa Healthcare

Q&A: CallisonRTKL’s Brad Barker

Chile’s Healthcare Expansion Lurches Forward

Veering between government and private spending, Chile, much like Brazil and Colombia, is building its healthcare infrastructure in fits and starts.

Q&A: CallisonRTKL’s Brad Barker

Q&A: Global Healthcare Accreditation, Karen Timmons

The teleradiology market is poised for growth thanks to the continued development of wireless technologies and expanded internet capacity. The market is projected to have an annual growth rate of 11.3% through 2023. However, high technology costs and a lack of experts in the field could come to hinder the market’s projected growth.

Japan Eyes Africa for Private Healthcare Investment

August 21, 2017

Japan's government is preparing to invest in the African healthcare sector via a US$30 billion public-private partnership under the African Business Education Initiative for Youth. This initiative will reportedly focus on key areas like infrastructure and the development of human resources. The African government is also reportedly collaborating with Japanese officials to figure out how to best utilize Japanese science and technologies across greater Africa.

Asia and MENA Experiencing Increase in Diabetes

August 21, 2017

The diabetes burden continues to rise across the globe, but particularly in Asia and MENA where professionals attribute the rise of the disease to the high number of expats and the Western diet and lifestyle influence they bring. The increase in diabetes cases continues to put pressure on healthcare providers as local costs and insurance premiums continue to rise and many cannot afford regular treatments. Healthcare providers across the two regions are calling for investments in early detection and management of the disease.

Time May be Running Out to Invest in Nigeria’s Healthcare Industry

August 21, 2017

Nigeria's Acting President, Yemi Osinbajo, urged healthcare investors to invest in Nigeria’s healthcare industry while speaking recently at the Nigerian Initiative for Economic Development. Osinbajo predicted Nigeria will become the sixth or seventh largest country in the world within the next decade. Nigeria's government, he added, views health investment as a top priority since medical tourism initiatives have brought losses of over US$1 billion to the country.

India Biosimilar Market Expected to Accelerate by 2030

August 21, 2017

The Indian biosimilar market is expected to reach US$40 billion by 2030, to make up 20% of the global market. This domestic market growth is being credited as a result of new pharmaceutical players surfacing, new products being successfully launched, and new regulatory pricing laws being put into effect in the country. Biosimilar manufacturers plan to tap into the market through increased investments and acquisitions.

Enter your email Address